ABIVAX Reports Impressive 12-month Efficacy and Safety Data from ABX464 Ulcerative Colitis Maintenance Study at United European Gastroenterology Conference

Written by Petra Hegmann on 21st October 2019. Posted in Client News.

• Previous
• Next